Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology

por Wu, Zhulin, Wei, Chunshan, Wang, Lianan, He, Li
Publicado 2021

In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma

por Wu, Zhulin, Kang, Jianyuan, Tan, Wanjun, Wei, Chunshan, He, Li, Jiang, Xiaoyan, Peng, Lisheng
Publicado 2022

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

por Laursen, Tea L, Hagemann, Christoffer A, Wei, Chunshan, Kazankov, Konstantin, Thomsen, Karen L, Knop, Filip K, Grønbæk, Henning
Publicado 2019

Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model

por Luo, Lidan, Wang, Shuai, Chen, Bohao, Zhong, Mei, Du, Ruili, Wei, ChunShan, Huang, Furong, Kou, Xinhui, Xing, Yufeng, Tong, Guangdong
Publicado 2022

Compound Phyllanthus urinaria L Inhibits HBV-Related HCC through HBx-SHH Pathway Axis Inactivation

por Li, Yun, Jiang, Mingjie, Li, Mingshun, Chen, Yingjie, Wei, Chunshan, Peng, Lisheng, Liu, Xinliang, Liu, Zhen, Tong, Guangdong, Zhou, Daqiao, He, Jinsong
Publicado 2019